Daclatasvir for hepatitis C: Added benefit not proven
Wednesday, December 10, 2014 - 16:31
in Health & Medicine
The data is unsuitable for virus genotype 4 patients and for untreated genotype 1 patients without cirrhosis; there is no data for genotype 3 patients and three other genotype 1 groups, researchers report after examination.
